This year the AFI Symposium in Rimini is back in attendance, after the 2-year stop due to Covid19 and IMS Micronizzazione will be present as an exhibitor at the AFI Symposium which will be held as usual at the Rimini Palacongressi, from 8 to 10 June 2022.
This event, now in its 61st edition, is confirmed with the most important Italian event for the pharmaceutical sector sponsored by AIFA.
The AFI Symposium brings together all the excellence of the pharmaceutical sector and will be an opportunity for comparison between Industry, Universities, Associations, Regulatory Bodies and for the construction of new business scenarios.
The AFI Symposium 2022 will be entitled “The Pharmaceutical World: the paradigms of a New Era” and will focus on the revolution that the scientific world has also passed through.
An irreversible revolution that projects us beyond the New Normality, into a new era for the Pharmaceutical World in which all companies in the sector are interested.
With this in mind, IMS Srl Micronizations will be present at the AFI Symposium with its stand and ready to discuss issues that concern it with customers and suppliers.
Program of the AFI Symposium in Rimini:
Wednesday 8th June
I Workshops (10:30 – 13:00)
Lectio Magistralis (14:00 – 15:00)
The Scientific Sessions on Wednesday (15:00 – 19:00)
Supply Chain session
Biotech & Clinical Research session
Thursday 9 June
The Scientific Sessions on Thursday (08:45 – 16:00)
Technological Innovation Session
AFI / CRS / ADRITELF session
HTA & Market Access session
Piazza delle Donne – Start Up Square (13:30 – 14:30)
The Poster Session (13:30 – 14:30)
The Plenary Session (16:30 – 18:30)
Friday 10th June
The Scientific Sessions on Friday (09:00 – 13:00)
Medical Devices Session
Who we are: IMS Srl exhibitor at the AFI Symposium in Rimini
IMS offers since 1973 integrated services in the treatment of APIs and excipients for the Pharmaceutical Industry.
The company IMS has extensive experience in the field of active ingredients and excipients micronization , with a large portfolio of non-european and european customers.
In order to achieve the improvement of its quality standards, the company is periodically inspected by the Italian Drug Agency (AIFA) and by the Food and Drug Administration (FDA).
IMS is accredited in Japan at PMDA and approved by the Korean Food and Drug Administration (KFDA) Administration.
The company is also certified ISO 9001:2015
Confirming the profound transformations taking place in the 4.0 pharmaceutical industry, the IMS Micronizations website is also expanding with advanced digital functions, including a virtual visit to the laboratories of the Milan office.
It is a tool composed of 360-degree images, intuitively navigable from all devices, which will allow the observer to make an immersive and interactive visit.
Thanks to the realistic rendering and the quality of the HD images, IMS Micronizations will be able to offer you an experience with a notable emotional impact.
To visit the virtual tour of the workshops click here